Healthy Skepticism Library item: 15613

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Arnold M, Comer B.
DDMAC, pharmas mull Web 2.0 rules
Medical Marketing & Media 2009 Apr 1
http://www.highbeam.com/doc/1G1-198169518.html

Full text:

DDMAC AND drug companies are talking about designing guidelines for social media, if mostly amongst themselves.

DDMAC has tasked Jean-Ah Kang, appointed special assistant to director Tom Abrams in January, with developing policy on pharma marketing and social media. Kang’s responsibilities, an FDA spokesperson said, include communications and policy and guidance development initiatives, among them, “the use of Web 2.0 tools to communicate information about prescription drugs.”

Meanwhile, regulatory and policy wonks at several companies, including Sanofi-Aventis US senior director, regulatory affairs Mark Gaydos, are working on hashing out suggestions for the agency on …